CRISPR and Abortion Access
Kathy highlights the groundbreaking approval of the first CRISPR-based therapies for sickle cell disease, marking a significant advancement in gene editing technology, despite their high costs. The conversation shifts to the ongoing challenges in abortion access post-Roe v. Wade, with a notable exodus of OBGYNs from restrictive states, reflecting a broader public support for abortion rights at 63%.In this clip
From this podcast
Science Friday
The Science That Captivated SciFri’s Reporters In 2024
Related Questions